Munich Re-backed Sepio Systems hits $15mn in funding

Insurtech (Insure Tech)

Fintech / Insurtech (Insure Tech) 168 Views

Global reinsurer Munich Re has acted as lead investor for Sepio Systems, a leader in Rogue Device Mitigation.

Sepio SystemsFollowing the recent Series A round, Sepio secured an additional $4 million from Munich Re Ventures and Hanaco Ventures, which brings the total investment in the company to $15 million.

Alongside the investment, Sepio has worked with Munich Re’s New Technologies and AI Underwriting team, where the reinsurance leader has validated Sepio’s approach to rogue device mitigation to decrease the customer’s overall hardware security risk.

Sepio will provide a performance guarantee to its customers backed by a subsidiary of Munich Re.

“Sepio is filling a critical gap in hardware security by providing visibility and management of attacks from an organization’s network to its physical layer,” said Jacqueline LeSage Krause, Managing Director, Munich Re Ventures.

“Sepio’s ability to fingerprint physical devices and detect rogue behavior is attracting interest from global organizations seeking to understand what rogue devices are living in their walls and on their networks. We look forward to working with Sepio on growing their market presence and product offering.”

“Our ability to offer instant detection and response to any threat or breach attempt coming from infected or manipulated devices has set Sepio apart and created incredible interest from the investment and customer community,” said Yossi Appleboum, Co-Founder & CEO, Sepio Systems.

“With a new R&D center in Lisbon and our expansion to Europe, with offices opening in the United Kingdom and Germany, Sepio is growing at an exponential rate and this additional funding is fueling that growth.

“Our partnership with Munich Re continues to expand our presence globally and highlights the synergy between insurance and RDM.”

The post Munich Re-backed Sepio Systems hits $15mn in funding appeared first on ReinsuranceNe.ws.

Comments